PPARG and lung carcinoma: MK866 blocks the 5-lipoxygenase pathway of arachidonic acidmetabolism, increases the expression of PPARα and PPARγ in breast cancer cells, and induces apoptosis [64].As well, in lung cancer cells, MK886 increased PPARγ reporter activity.